These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11131733)

  • 21. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
    Taneepanichskul S; Sirinavin S; Phuapradit W; Chaturachinda K
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):329-31. PubMed ID: 9325519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
    Limpongsanurak S; Thaithumyanon P; Thisyakorn U; Ruxrungtham K; Chaithongwongwatthana S; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P
    J Med Assoc Thai; 2001 May; 84(5):611-6. PubMed ID: 11560207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(8):151-4. PubMed ID: 9518278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.
    Thaithumyanon P; Thisyakorn U; Limpongsanurak S; Chaithongwongwatthana S; Punnahitanon S; Ubolyam S; Phanuphak P; Ruxrungtham K; Virutamasen P
    J Med Assoc Thai; 2001 Sep; 84(9):1229-34. PubMed ID: 11800293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
    Bhoopat L; Khunamornpong S; Lerdsrimongkol P; Sirivatanapa P; Sethavanich S; Limtrakul A; Gomutbuthra V; Kajanavanich S; Thorner PS; Bhoopat T
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):545-50. PubMed ID: 16284530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short course of AZT halves HIV-1 perinatal transmission.
    Morris K
    Lancet; 1998 Feb; 351(9103):651. PubMed ID: 9500334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
    Palmer AL; Gay H; Currier MM
    J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.
    Dabis F; Msellati P; Meda N; Welffens-Ekra C; You B; Manigart O; Leroy V; Simonon A; Cartoux M; Combe P; Ouangré A; Ramon R; Ky-Zerbo O; Montcho C; Salamon R; Rouzioux C; Van de Perre P; Mandelbrot L
    Lancet; 1999 Mar; 353(9155):786-92. PubMed ID: 10459959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the prevention of mother-to-child transmission of HIV-1 infection in resource-limited settings.
    Ekouevi DK; Tonwe-Gold B; Dabis F
    AIDS Read; 2005 Sep; 15(9):479-80, 487-93. PubMed ID: 16170877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation.
    Wortley PM; Lindegren ML; Fleming PL
    MMWR Recomm Rep; 2001 May; 50(RR-6):17-28. PubMed ID: 15580801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV.
    Dabis F; Newell ML; Fransen L; Saba J; Lepage P; Leroy V; Cartoux M; Meda N; Whynes DK; Peckham C; Nduati R; Msellati P; Vincenzi ID; van de Perre P
    Health Policy Plan; 2000 Mar; 15(1):34-42. PubMed ID: 10731233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zidovudine.
    Sperling R
    Infect Dis Obstet Gynecol; 1998; 6(5):197-203. PubMed ID: 9894173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Jourdain G; Mary JY; Coeur SL; Ngo-Giang-Huong N; Yuthavisuthi P; Limtrakul A; Traisathit P; McIntosh K; Lallemant M;
    J Infect Dis; 2007 Dec; 196(11):1629-36. PubMed ID: 18008246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric HIV-1 infection: updated strategies of prevention mother-to-child transmission.
    Lumaca A; Galli L; de Martino M; Chiappini E
    J Chemother; 2018 Jul; 30(4):193-202. PubMed ID: 29595094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.